Defining the roles of macrophages subsets and NK lymphocytes in silicosis
定义巨噬细胞亚群和 NK 淋巴细胞在矽肺中的作用
基本信息
- 批准号:7533989
- 负责人:
- 金额:$ 30.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-12-12 至 2011-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAlveolar MacrophagesAnimal ModelBiological ModelsBreathingCellsChronicComplexDataDeveloped CountriesDeveloping CountriesDevelopmentElementsEnvironmentEventExposure toFibrosisFluorescence MicroscopyGenerationsHealthImmune responseIn VitroInflammationInflammatoryKnockout MiceKnowledgeLaboratoriesLearningLungLung InflammationLymphocyteLymphocyte ActivationMaintenanceModelingMolecularMusNatural Killer CellsNatureOccupationalPhenotypePlayPopulationProcessRelative (related person)Respiratory SystemRoleSignal PathwaySignal TransductionSignaling MoleculeSilicon DioxideSilicosisSynapsesTestingTherapeuticUnited StatesWorkWorkplacecellular targetingcytokineeffective therapyfibrogenesisin vivo Modelinterstitialmacrophagenew therapeutic targetnovelrespiratorytooltraffickingtreatment strategy
项目摘要
Crystalline silica is well known to induce chronic lung inflammation that can progress to fibrosis, i.e.
silicosis. Despite existing standards, silicosis remains a prevalent health problem in the United States and
throughout the world. Because it is a known causative agent of lung fibrosis, it is often used to study
mechanisms of fibrogenesis under controlled conditions in animal models. While much has been learned,
there is still insufficient information on the molecular and cellular mechanisms leading to fibrosis to develop
effective therapeutic approaches. It is generally acceptedthat alveolar macrophages are the initial cellular
targets following silica inhalation and that macrophagesare involved in the initiation of inflammatory signals
and that mostly likely lymphocytes are also involved, since Th1- and Th2- associated cytokines have been
repeatedly implicated in the process of fibrosis. Basedon recent data from our laboratory, as well as
others, implicating activated lung macrophages (aM0) and NK lymphocytes as being sufficient to set off the
inflammatory cycle leading to fibrosis we propose to test the central hypothesis that aM0 with NK
lymphocytes constitute steps in the development of chronic inflammation progressing to silicosis. We will
use the following three aims to test this hypothesis: Specific Aim 1: Characterize the silica-exposed alveolar
macrophages that traffic to the interstitial spaces, acquire an immunostimulatory phenotype, and play an
integral role in the generation of the aM0. Specific Aim 2: Demonstrate that NK activation by the aM0 is
sufficient to generatethe inflammatory requirements for lung fibrosis. Specific Aim 3: Ascertain the nature
and molecular components of the aM0-NK interface that results in the generation of a pro-fibrotic
environment. This proposal is novel in that it will address the complex interactions between aM0 and NK
within the context of the respiratory system using both in vitro and in vivo models. Upon completion of
these studies, we expect to establish and test the relative contributions of specific subpopulations of
macrophages and NK cells and determine those candidate molecules and signaling pathways by which
these cells communicate leading to chronic inflammation and fibrosis. Furthermore, this body of work is
anticipated to generate knowledge that will direct the development of novel therapeutic targets for the
management of respiratory illnesses, including silica-induced inflammation and fibrosis.
众所周知,结晶二氧化硅可诱导慢性肺部炎症,其可进展为纤维化,即肺纤维化。
矽肺病尽管有现有的标准,矽肺仍然是美国普遍存在的健康问题,
在全世界都有。因为它是一种已知的肺纤维化的病原体,它经常被用来研究
在动物模型中控制条件下的纤维化机制。虽然已经学到了很多,
关于导致纤维化发展的分子和细胞机制的信息仍然不足
有效的治疗方法。一般认为肺泡巨噬细胞是最初的细胞,
目标后二氧化硅吸入和巨噬细胞参与启动炎症信号
而且最有可能的是淋巴细胞也参与其中,因为Th 1和Th 2相关的细胞因子已经被发现,
反复参与纤维化过程。根据我们实验室的最新数据,
另一些人认为,激活的肺巨噬细胞(aM 0)和NK淋巴细胞足以引发
我们提出,通过研究导致纤维化的炎性周期,我们可以检验中心假设,即aM 0与NK
淋巴细胞构成了慢性炎症发展到矽肺的步骤。我们将
使用以下三个目标来检验这一假设:具体目标1:表征二氧化硅暴露的肺泡
巨噬细胞运输到间质空间,获得免疫刺激表型,并发挥免疫调节作用。
在aM 0的生成中起着不可或缺的作用。具体目标2:证明aM 0的NK活化是
足以产生肺纤维化的炎症需求。具体目标3:确定性质
以及导致促纤维化蛋白生成的aM 0-NK界面的分子组分
环境该提议是新颖的,因为它将解决aM 0和NK之间的复杂相互作用
在使用体外和体内模型的呼吸系统的情况下。完成后
这些研究,我们希望建立和测试特定亚群的相对贡献,
巨噬细胞和NK细胞,并确定那些候选分子和信号通路,
这些细胞相互交流导致慢性炎症和纤维化。此外,这项工作是
预计将产生的知识,将指导新的治疗目标的发展,
呼吸道疾病的管理,包括二氧化硅引起的炎症和纤维化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrij Holian其他文献
Andrij Holian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrij Holian', 18)}}的其他基金
Improving middle grade STEM interest and increased learning using GN and DOC
使用 GN 和 DOC 提高中年级 STEM 兴趣并增加学习
- 批准号:
10665328 - 财政年份:2023
- 资助金额:
$ 30.8万 - 项目类别:
Role of particle surface functionalization in inflammation
颗粒表面功能化在炎症中的作用
- 批准号:
10810001 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Lysosomal BK channel regulates cSiO2-induced macrophage inflammation
溶酶体 BK 通道调节 cSiO2 诱导的巨噬细胞炎症
- 批准号:
10618324 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Role of particle surface functionalization in inflammation
颗粒表面功能化在炎症中的作用
- 批准号:
10618289 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Role of particle surface functionalization in inflammation
颗粒表面功能化在炎症中的作用
- 批准号:
10714399 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Role of particle surface functionalization in inflammation
颗粒表面功能化在炎症中的作用
- 批准号:
10463190 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Lysosomal BK channel regulates cSiO2-induced macrophage inflammation
溶酶体 BK 通道调节 cSiO2 诱导的巨噬细胞炎症
- 批准号:
10463030 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Differential responses of males and females to multi-walled carbon nanotubes
男性和女性对多壁碳纳米管的不同反应
- 批准号:
10266754 - 财政年份:2020
- 资助金额:
$ 30.8万 - 项目类别:
Differential responses of males and females to multi-walled carbon nanotubes
男性和女性对多壁碳纳米管的不同反应
- 批准号:
9912608 - 财政年份:2020
- 资助金额:
$ 30.8万 - 项目类别:
Dietary DHA attenuation of nanoparticle inflammation
膳食 DHA 减轻纳米颗粒炎症
- 批准号:
9164796 - 财政年份:2014
- 资助金额:
$ 30.8万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 30.8万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 30.8万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 30.8万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 30.8万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 30.8万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 30.8万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 30.8万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 30.8万 - 项目类别: